B1MLM Cell death induction peptide by B1MLM

The present invention relates to a novel cell death induction peptide. Specifically, the present invention relates to a cell death induction peptide developed after discovering that MTD-like cell death induction peptide B1MLM derived from Bnip1 protein kills cancer cells; and a cell death induction...

Full description

Saved in:
Bibliographic Details
Main Authors KIM TAE HYOUNG, HAN JI HYE, PARK JUNGHEE, MYUNG SEUNG HYUN
Format Patent
LanguageEnglish
Korean
Published 25.06.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel cell death induction peptide. Specifically, the present invention relates to a cell death induction peptide developed after discovering that MTD-like cell death induction peptide B1MLM derived from Bnip1 protein kills cancer cells; and a cell death induction fusion protein comprising the same. 본 발명은 새로운 세포사 유도 펩타이드에 관한 것으로서, 구체적으로는Bnip1 단백질에서 유래한 MTD 유사 세포사 유도 펩타이드 B1MLM이 암세포를 죽이는 것을 발견하고 개발한 세포사 유도 펩타이드와 이를 포함하는 세포사 유도 융합단백질에 관한 것이다.
Bibliography:Application Number: KR20170172955